BD推出新的细胞分析仪配置，为各种规模的实验室带来前沿功能-动脉网

BD Launches New Cell Analyzer Configurations to Bring Cutting-Edge Capabilities to Labs of All Sizes

碧迪医疗等信源发布 2025-12-03 19:52



可切换为仅中文







Three- and Four-Laser BD FACSDiscover™ A8 Cell Analyzers Expand Accessibility of Spectral, Real-Time Imaging Cell Analysis

三激光和四激光BD FACSDiscover™ A8细胞分析仪扩展了光谱、实时成像细胞分析的可及性

FRANKLIN LAKES, N.J.

富兰克林湖，新泽西州

，

Dec. 3, 2025

2025年12月3日

PRNewswire

美通社

/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the global commercial release of new configurations of cell analyzers featuring breakthrough spectral and real-time cell imaging technologies, enabling more labs in academia, pharma and biotech – across scales, needs and budgets – to advance discoveries in immunology, cancer immunotherapy and cell biology..

/ -- BD（Becton, Dickinson and Company）（纽约证券交易所代码：BDX），一家全球领先的医疗技术公司，今天宣布在全球范围内商业发布采用突破性光谱和实时细胞成像技术的新型细胞分析仪配置，使学术界、制药和生物技术领域的更多实验室——涵盖不同规模、需求和预算——能够在免疫学、癌症免疫治疗和细胞生物学领域推动发现。

The new BD FACSDiscover™ A8 Cell Analyzers feature BD SpectralFX™ Technology, which allows scientists to analyze up to 50 or more characteristics of a single cell with optimal resolution and sensitivity, and BD CellView™ Image Technology, which enables high-speed imaging, revealing spatial and morphological insights – like the location of a protein within a single cell – that can be visually analyzed in real time.

新型BD FACSDiscover™ A8细胞分析仪配备了BD SpectralFX™技术，可让科学家以最佳分辨率和灵敏度分析单个细胞多达50种或更多特征，并配备了BD CellView™图像技术，能够实现高速成像，揭示空间和形态学信息——例如单个细胞内蛋白质的位置——并可实时进行可视化分析。

The three- and four-laser additions to the BD FACSDiscover™ A8 Cell Analyzer portfolio complement the five-laser instrument launched earlier this year, providing more scientists worldwide the opportunity to incorporate industry-leading capabilities in their labs. Both versions have the option to start with a free trial of CellView™ Image Technology and upgrade later via software – giving labs further flexibility..

三激光和四激光的BD FACSDiscover™ A8细胞分析仪系列新品，是对今年早些时候发布的五激光仪器的补充，为全球更多科学家提供了在实验室中引入行业领先技术的机会。这两个版本均可选择先免费试用CellView™图像技术，之后再通过软件升级，为实验室提供更多灵活性。

'The BD FACSDiscover™ A8 Cell Analyzer has become our new standard, changing how our flow cytometry core operates,' said Gert Van Isterdael, head of VIB Flow Core Ghent. 'Once you experience the integration of spectral and imaging data, you don't want to go back. It opens a new dimension for our work, helping us see more, understand faster, and enable discoveries that simply weren't possible before.

“BD FACSDiscover™ A8细胞分析仪已成为我们的新标准，改变了我们流式细胞术核心的运作方式，”VIB Flow Core Ghent负责人Gert Van Isterdael表示。“一旦你体验到光谱和成像数据的整合，就不会想再回头了。它为我们工作开启了新的维度，帮助我们看到更多、理解更快，并实现以前无法做到的发现。”

The BD FACSDiscover™ A8 Cell Analyzer is a game changer, and having more configurations will only make this leading technology more accessible to a wider range of labs.'.

BD FACSDiscover™ A8 细胞分析仪是一项颠覆性的技术，拥有更多配置只会让这项领先的技术被更广泛的实验室所使用。

All configurations of the BD FACSDiscover™ A8 Cell Analyzer feature high-throughput, walkaway automation that enables best-in-class cost-per-insight economics through real-time imaging. The intuitive software makes it easy to manage large datasets, and is designed for out-of-the-box standardization.

BD FACSDiscover™ A8 细胞分析仪的所有配置均具备高通量、无人值守的自动化功能，通过实时成像实现业内最佳的单次洞察成本效益。直观的软件使管理大型数据集变得轻松，并专为开箱即用的标准化而设计。

The analyzers also pair seamlessly with the ecosystem of BD FACSDiscover™ Cell Sorters and BD Reagents. This includes the recently launched BD Horizon RealViolet™ 828 and RealBlue™ 824 fluorochromes, pioneering entries into the near-infrared spectrum that, when used with a cell analyzer, can unlock new discoveries through spectral flow cytometry..

分析仪还与BD FACSDiscover™细胞分选仪和BD试剂的生态系统无缝配对。这包括最近推出的BD Horizon RealViolet™ 828和RealBlue™ 824荧光染料，这些是近红外光谱领域的开创性产品，当与细胞分析仪一起使用时，可以通过光谱流式细胞术解锁新的发现。

'In today's complex research landscape, access to leading-edge technologies through flexibility and modularity is crucial, from basic to translational science,' said

“在当今复杂的科研环境中，从基础科学到转化科学，通过灵活性和模块化获取尖端技术是至关重要的，”

Steve Conly

史蒂夫·康利

, worldwide president of BD Biosciences. 'Alongside the entire BD ecosystem of sorters, reagents, and informatics, the BD FACSDiscover™ A8 Cell Analyzer continues to be rapidly adopted by leading biopharmaceutical companies, and now with more entry points, organizations of all sizes can access the same technology.'.

BD生物科学全球总裁。“随着整个BD生态系统（包括分选仪、试剂和信息学）的发展，BD FACSDiscover™ A8细胞分析仪继续被领先的生物制药公司迅速采用，并且现在有了更多的切入点，各种规模的组织都可以使用相同的技术。”

BD FACSDiscover™ A8 Cell Analyzers are now available to order through local sales representatives. For researchers facing capital expenditure constraints, flexible financing options are now available. More information is available at bdbiosciences.com.

BD FACSDiscover™ A8 细胞分析仪现在可以通过当地销售代表订购。对于面临资本支出限制的研究人员，现在提供灵活的融资选项。更多信息可访问 bdbiosciences.com。

About BD

关于BD

BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of health care by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for health care providers.

BD是全球最大的医疗技术公司之一，通过改进医学发现、诊断和护理服务，推动健康领域的发展。公司通过开发创新的技术、服务和解决方案，支持医疗保健领域的前线英雄，帮助推进患者的临床治疗和医疗服务提供者的临床流程。

BD and its more than 70,000 employees have a passion and commitment to help enhance the safety and efficiency of clinicians' care delivery process, enable laboratory scientists to accurately detect disease and advance researchers' capabilities to develop the next generation of diagnostics and therapeutics.

BD及其超过70,000名员工充满热情和承诺，致力于帮助提升临床医生护理过程的安全性和效率，使实验室科学家能够准确检测疾病，并推动研究人员开发下一代诊断和治疗方法的能力。

BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care.

BD几乎在每个国家都有业务，并与世界各地的组织合作，应对一些最具挑战性的全球健康问题。通过与客户密切合作，BD可以帮助改善结果、降低成本、提高效率、增强安全性并扩大医疗保健的可及性。

For more information on BD, please visit .

有关 BD 的更多信息，请访问。

bd.com

or connect with us on LinkedIn at

或通过以下方式在LinkedIn上与我们联系

www.linkedin.com/company/bd1/

, X (formerly Twitter)

，X（前身为Twitter）

@BDandCo

or Instagram

或 Instagram